News Article
Disruption has arrived for ‘big pharma’
21 December 2017
Candesic’s Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space.
Candesic’s Dr Niklas Jahn and Dr Michelle Tempest suggest a silver lining for investors in the drug discovery and biotech space.